Policy Perspective
COGR Testimony at NIH Hearings on March-in Rights
NIH has denied the request from Essential Inventions, Inc. to exercise march-in rights under The Bayh-Dole Act in connection with the pricing of Norvir, marketed by Abbott Laboratories for the treatment of patients with HIV/AIDS. The decision and related materials are available online.
Miscellaenous
The revised Information Quality Bulletin for Peer Review, issued by the Office of Information and Regulatory Affairs (OIRA) within the Office of Management and Budget (OMB), provides updated and detailed guidance to federal agencies regarding the peer review of influential scientific information disseminated to the public. Unlike the prior guidelines, which merely encouraged peer review, this Bull
Final Comments on NIH Guidelines on Recombinant or Synthetic Nucelic Acid Molecules
The Council on Governmental Relations (COGR), representing 190 research universities and associated medical centers, submitted comments to the NIH Office of Science Policy regarding proposed amendments to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. COGR generally supports the NIH’s intentions to streamline oversight of human gene transfer protocols by
